CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$8,048,000
+60.8%
426,698
+0.3%
0.01%
+66.7%
Q2 2019$5,005,000
-3.9%
425,222
+11.5%
0.00%0.0%
Q1 2019$5,206,000
+56.1%
381,373
+17.3%
0.00%0.0%
Q4 2018$3,334,000
-38.9%
325,190
-0.8%
0.00%
-25.0%
Q3 2018$5,458,000
+8.9%
327,756
+3.4%
0.00%0.0%
Q2 2018$5,010,000
+32.1%
317,082
+6.2%
0.00%
+33.3%
Q1 2018$3,794,000
+7.5%
298,667
-3.1%
0.00%0.0%
Q4 2017$3,530,000
+10.6%
308,250
+18.4%
0.00%0.0%
Q3 2017$3,191,000
+42.6%
260,434
+33.3%
0.00%
+50.0%
Q2 2017$2,238,000
-48.6%
195,446
-6.6%
0.00%
-50.0%
Q1 2017$4,353,000
+22.3%
209,273
+22.3%
0.00%0.0%
Q4 2016$3,560,000
-34.6%
171,150
+3.1%
0.00%
-33.3%
Q3 2016$5,440,000
+37.8%
165,990
+5.0%
0.01%
+20.0%
Q2 2016$3,947,000
+80.1%
158,058
+76.7%
0.01%
+66.7%
Q1 2016$2,191,000
-24.2%
89,448
+2.2%
0.00%
-25.0%
Q4 2015$2,892,000
+22.7%
87,548
+21.7%
0.00%
+33.3%
Q3 2015$2,357,000
+49.6%
71,932
+141.8%
0.00%
+50.0%
Q2 2015$1,576,000
+227.0%
29,746
+78.1%
0.00%
+100.0%
Q1 2015$482,000
+41.3%
16,700
+42.7%
0.00%0.0%
Q4 2014$341,000
+128.9%
11,7000.0%0.00%
Q3 2014$149,000
-36.6%
11,7000.0%0.00%
Q2 2014$235,00011,7000.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders